Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD d...

Descripción completa

Detalles Bibliográficos
Autores principales: Noya, MSoledad, Andrade‐Campos, Marcio, Irun, Pilar, López de Frutos, Laura, López‐Fernandez, MFernanda, Giraldo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930224/
https://www.ncbi.nlm.nih.gov/pubmed/29744080
http://dx.doi.org/10.1002/ccr3.1460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930224/
https://www.ncbi.nlm.nih.gov/pubmed/29744080
http://dx.doi.org/10.1002/ccr3.1460

Ejemplares similares